FDA Approves Polarizing First Drug for Duchenne Muscular Dystrophy

On Monday morning, the FDA controversially approved the first drug for Duchenne muscular dystrophy. Read more on how the drug works and what impact this will have in healthcare and medicine!

Advertisements